BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16967031)

  • 21. Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
    Bramer JA; Abudu AA; Grimer RJ; Carter SR; Tillman RM
    Eur J Cancer; 2007 Sep; 43(13):1944-51. PubMed ID: 17698347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases--an experience in northern Japan.
    Okada K; Hasegawa T; Nishida J; Ogose A; Tajino T; Osanai T; Yanagisawa M; Hatori M
    Ann Surg Oncol; 2004 Nov; 11(11):998-1004. PubMed ID: 15525829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. En bloc resections for osteogenic sarcoma.
    Marcove RC; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):165-8. PubMed ID: 6946289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment results of pediatric osteosarcoma: twenty-year experience.
    Varan A; Yazici N; Aksoy C; Gedikoğlu G; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    J Pediatr Orthop; 2007 Mar; 27(2):241-6. PubMed ID: 17314654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-erbB-2 expression and prognostic significance in osteosarcoma.
    Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group.
    Nishida Y; Isu K; Ueda T; Nishimoto Y; Tsuchiya H; Wada T; Sato K; Tsukushi S; Sugiura H
    J Surg Oncol; 2009 Jul; 100(1):48-54. PubMed ID: 19384906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth patterns of osteosarcoma predict patient survival.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
    Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periosteal osteosarcoma: long-term outcome and risk of late recurrence.
    Rose PS; Dickey ID; Wenger DE; Unni KK; Sim FH
    Clin Orthop Relat Res; 2006 Dec; 453():314-7. PubMed ID: 16906092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periosteal osteosarcoma--a European review of outcome.
    Grimer RJ; Bielack S; Flege S; Cannon SR; Foleras G; Andreeff I; Sokolov T; Taminiau A; Dominkus M; San-Julian M; Kollender Y; Gosheger G;
    Eur J Cancer; 2005 Dec; 41(18):2806-11. PubMed ID: 16290134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in pediatric solid tumors.
    Fuchs J; Seitz G; Ellerkamp V; Dietz K; Bosk A; Müller I; Warmann SW; Schäfer JF
    Surg Oncol; 2008 Dec; 17(4):323-30. PubMed ID: 18586485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteosarcoma in Finland from 1971 through 1990: a nationwide study of epidemiology and outcome.
    Sampo MM; Tarkkanen M; Kivioja AH; Taskinen MH; Sankila R; Böhling TO
    Acta Orthop; 2008 Dec; 79(6):861-6. PubMed ID: 19085506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.
    Jasnau S; Meyer U; Potratz J; Jundt G; Kevric M; Joos UK; Jürgens H; Bielack SS;
    Oral Oncol; 2008 Mar; 44(3):286-94. PubMed ID: 17467326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.
    Cates JM; Schoenecker JG
    Acta Oncol; 2016 Aug; 55(8):1036-9. PubMed ID: 27145235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typical and atypical osteosarcomas: a clinicopathologic study of sixty-two cases.
    Machinami R; Imamura T; Takeyama S; Tateishi A
    Gan; 1979 Oct; 70(5):621-38. PubMed ID: 293282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-grade osteosarcoma, review of 15 cases in a series of 156 osteosarcoma cases.
    Arslan HS; Aydin O; Dervışoğlu S; Oksüz DC; Kantarci F; Hiz M; Dınçbaç FO; Mandel NM
    Turk Patoloji Derg; 2011 May; 27(2):138-43. PubMed ID: 21630200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection arthrodesis of the knee for osteosarcoma: an alternative when mobile joint reconstruction is not feasible.
    Shih HN; Shih LY
    Chang Gung Med J; 2005 Jun; 28(6):411-20. PubMed ID: 16124157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. time dependency of prognostic factors in patients with stage II osteosarcomas.
    Kim MS; Cho WH; Song WS; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Oct; 463():157-65. PubMed ID: 17621233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.